NewsBenzinga몰레큘러 파트너스, SITC 2026에서 발표한 MP0632 전임상 데이터가 건강한 중피세포 또는 상피세포에 미치는 영향이 감지되지 않아 MSLN 및 EpCAM 고형암에 대한 IND 지원 연구를 뒷받침한다고 발표 몰레큘러 파트너스, SITC 2026에서 발표한 MP0632 전임상 데이터가 건강한 중피세포 또는 상피세포에 미치는 영향이 감지되지 않아 MSLN 및 EpCAM 고형암에 대한 IND 지원 연구를 뒷받침한다고 발표 Benzinga 2026.11.06 06:14 (GMT+0) Open on Benzinga Other news Mastercard Obtains Two Patents: Assessing Money Laundering Risk Before Crypto Transfers and Protecting Privacy $U and Laguna Network Launch Exclusive Travel Cashback for BBW 2026 Bangkok Attendees, With Fully Expanded Platform Support Elon Musk Confirms Cybertruck Production Wind-Down at Texas Factory as Tesla Makes Room for Cybercab VEON Q3 EPS $2.67 Beats $1.57 Estimate, Sales $1.307B Miss $1.308B Estimate What Are Wall Street Analysts' Target Price for Williams Companies Stock? Analysis: As Long as the Stock Sell-Off Persists, the Risk of Further De-Risking in Crypto Markets Remains
Mastercard Obtains Two Patents: Assessing Money Laundering Risk Before Crypto Transfers and Protecting Privacy
$U and Laguna Network Launch Exclusive Travel Cashback for BBW 2026 Bangkok Attendees, With Fully Expanded Platform Support
Analysis: As Long as the Stock Sell-Off Persists, the Risk of Further De-Risking in Crypto Markets Remains